CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF
申请人:MILLENNIUM PHARMACEUTICALS, INC.
公开号:EP1448566A2
公开(公告)日:2004-08-25
[EN] CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF<br/>[FR] ANTAGONISTES DES RECEPTEURS DE LA CHIMIOKINE ET METHODES D'UTILISATION DE CES ANTAGONISTES
申请人:MILLENNIUM PHARM INC
公开号:WO2003045942A2
公开(公告)日:2003-06-05
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: formula (1) or physiologically acceptable salt thereof.